Document is current
Any future updates will be listed below
-
Authors
Merino-Cacho, Laura
Barroso-Gomila, Orhi
Pozo-Rodríguez, Mónica
Muratore, Veronica
Guinea-Pérez, Claudia
Serrano, Álvaro
Pérez, Coralia
Cano-López, Sandra
Urcullu, Ainhoa
Azkargorta, Mikel
Iloro, Ibon
Galdeano, Carles
Juárez-Jiménez, Jordi
Mayor, Ugo
Elortza, Felix
Barrio, Rosa
Sutherland, James D.
-
Funding
Funding for this research was provided by:
Ministerio de Universidades (FPU20/05282)
HORIZON EUROPE Marie Sklodowska-Curie Actions (765445-EU, UbiCODE Program, 765445-EU, UbiCODE Program, 765445-EU, UbiCODE Program)
Ministerio de Ciencia e Innovación (PRE2022-104553, PRE2018-086230, PRE2021-099359, PREP2023-000294)
Cooperation for Science & Technology COST Action (ProteoCure CA20113, ProteoCure CA20113, ProteoCure CA20113, ProteoCure CA20113)
Computational Biology Drug Design Consolidated Research Group, Generalitat de Catalunya (2021SGR00671, 2021SGR00671)
Ministerio de Ciencia, Innovación y Universidades (CNS2022-135307, PID2020-117333GB-I00, PID2023-147399NB-I00, PID2020-114178GB-I00, CEX2021-001136-S, CEX2021-001202-M, PID2023-147399NB-I00, PID2020-114178GB-I00, CEX2021-001136-S, CEX2021-001202-M)
European Union NextGeneration EU/PRTR
Red Española de Supercomputación (BCV-2021-3-0006, BCV-2021-2-0005)
Diputación Foral de Bizkaia (6/12/TT/2023 /00001, 6/12/TT/2023 /00001)
- License Information
-
More Information
Article History
Received: 25 October 2024
Accepted: 8 February 2025
First Online: 19 February 2025
Declarations
:
: Not applicable.
: Not applicable.
: C.G. is co-founder and Drug Discovery Scientific Advisor of Oniria Therapeutics. The other authors declare that they have no competing interests.
